Literature DB >> 18766630

Maternally-derived antibody to infectious bronchitis virus: Its detection in chick trachea and serum and its role in protection.

A P Mockett1, J K Cook, M B Huggins.   

Abstract

Chicks with maternally-derived IgG antibodies to infectious bronchitis virus (IBV) were protected against challenge with a mixture of IBV and Escherichia coli. This protective immunity lasted for at least 1 week. IBV-specific IgG was detected, using an ELISA, in the majority of tracheal washes taken from chicks aged 1 day and 1 week that had been hatched from IBV-infected hens. Some of the 2-week-old chicks also had detectable antibody. This tracheal IgG may be an important factor in mediating protective immunity. The origin and transport of the IgG into the trachea are discussed. IBV-specific IgG was detected in chick serum and had a half-life of 4.5 days. Yolk samples, collected from eggs laid by IBV-infected hens, were tested for the presence of viral-specific IgG antibodies. The sequential IgG antibody response to IBV in yolk was determined. Specific antibodies were detected at highest concentrations 16 to 18 days after infection and then declined. A second inoculation of an inactivated oil-based vaccine induced high concentrations of IBV-specific antibodies in the yolk which were maintained for the 60 days of the experiment. Detection of specific IgG in the yolk could be used as a means of assessing response to vaccination.

Entities:  

Year:  1987        PMID: 18766630     DOI: 10.1080/03079458708436391

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  5 in total

1.  A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.

Authors:  Shaswath S Chandrasekar; Brock Kingstad-Bakke; Chia-Wei Wu; M Suresh; Adel M Talaat
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

2.  Maternal antibody to infectious bronchitis virus: its role in protection against infection and development of active immunity to vaccine.

Authors:  S P Mondal; S A Naqi
Journal:  Vet Immunol Immunopathol       Date:  2001-05-10       Impact factor: 2.046

3.  Pharmacokinetics of ceftriaxone-tazobactam (8:1) combination in healthy and Escherichia coli induced diarrhoeic birds.

Authors:  U C Mithin; Rinku Buragohain; Pradip K Das; Tapan K Mandal; Rabindra N Hansda; Siddhartha N Joardar; Indranil Samanta; Tapas K Sar
Journal:  ADMET DMPK       Date:  2022-09-13

4.  Infectious bronchitis virus: Immunopathogenesis of infection in the chicken.

Authors:  G D Raj; R C Jones
Journal:  Avian Pathol       Date:  1997       Impact factor: 3.378

5.  Polymorphisms in the S1 spike glycoprotein of Arkansas-type infectious bronchitis virus (IBV) show differential binding to host tissues and altered antigenicity.

Authors:  Christina Leyson; Monique França; Mark Jackwood; Brian Jordan
Journal:  Virology       Date:  2016-09-15       Impact factor: 3.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.